Mayo clinic tests if common heart drugs can shield cancer patients from Chemo's hidden heart risk
NCT ID NCT07456852
Summary
This study aims to see if certain blood pressure medications can protect the heart's blood vessels from damage caused by common chemotherapy drugs for stomach and colon cancers. Researchers will monitor 60 patients with gastrointestinal cancer who are receiving drugs like 5-FU or capecitabine, which can sometimes cause chest pain or heart issues. The study will first measure how often these patients develop blood vessel problems, then test if medications like isosorbide mononitrate or diltiazem can prevent or reduce these harmful side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT DIGESTIVE SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.